Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy Sutherland

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Harm Reduction Journal|July 14, 2022
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19Karen McCrae, Stephanie Glegg, Marie-Éve Goyer, et al.
Drug and Alcohol Review|November 4, 2025
Community Pharmacy-Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot ProgramTamara Mihic, Maria Eugenia Socias, Karen McCrae, et al.
American Journal of Public Health|April 17, 2020
A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, CanadaMichelle Olding, Andrew Ivsins, Samara Mayer, et al.
CMAJ Open|February 24, 2021
Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scansErin Eydt, Stephanie Glegg, Christy Sutherland, et al.
Harm Reduction Journal|June 24, 2021
"If I knew I could get that every hour instead of alcohol, I would take the cannabis": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programsBernie Pauly, Meaghan Brown, Clifton Chow, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 25, 2019
Injectable opioid agonist treatment for opioid use disorder: a national clinical guidelineNadia Fairbairn, Josey Ross, Michael Trew, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2025
Frozen in Addiction: A New Wave of Drug-Induced Movement Disorders?Christos Ganos, Roberto Erro, Mohammad Abdullah, et al.
The International Journal on Drug Policy|June 9, 2022
"COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in CanadaStephanie Glegg, Karen McCrae, Gillian Kolla, et al.
Substance Abuse Treatment, Prevention, and Policy|February 21, 2024
An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort studyRukaiyah Lakkadghatwala, Daniel Lane, Frank Scheuermeyer, et al.
The International Journal on Drug Policy|November 11, 2023
Translating the lived experience of illicit drinkers into program guidance for cannabis substitution: Experiences from the Canadian Managed Alcohol Program StudyAaron Bailey, Myles Harps, Clint Belcher, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Harm Reduction Journal|July 14, 2022
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19Karen McCrae, Stephanie Glegg, Marie-Éve Goyer, et al.
Drug and Alcohol Review|November 4, 2025
Community Pharmacy-Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot ProgramTamara Mihic, Maria Eugenia Socias, Karen McCrae, et al.
American Journal of Public Health|April 17, 2020
A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, CanadaMichelle Olding, Andrew Ivsins, Samara Mayer, et al.
CMAJ Open|February 24, 2021
Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scansErin Eydt, Stephanie Glegg, Christy Sutherland, et al.
Harm Reduction Journal|June 24, 2021
"If I knew I could get that every hour instead of alcohol, I would take the cannabis": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programsBernie Pauly, Meaghan Brown, Clifton Chow, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 25, 2019
Injectable opioid agonist treatment for opioid use disorder: a national clinical guidelineNadia Fairbairn, Josey Ross, Michael Trew, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2025
Frozen in Addiction: A New Wave of Drug-Induced Movement Disorders?Christos Ganos, Roberto Erro, Mohammad Abdullah, et al.
The International Journal on Drug Policy|June 9, 2022
"COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in CanadaStephanie Glegg, Karen McCrae, Gillian Kolla, et al.
Substance Abuse Treatment, Prevention, and Policy|February 21, 2024
An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort studyRukaiyah Lakkadghatwala, Daniel Lane, Frank Scheuermeyer, et al.
The International Journal on Drug Policy|November 11, 2023
Translating the lived experience of illicit drinkers into program guidance for cannabis substitution: Experiences from the Canadian Managed Alcohol Program StudyAaron Bailey, Myles Harps, Clint Belcher, et al.
Pageof 4